Riskpilot← Back to searchSign inGet full accessNQ Neuroquant AB
ABActiveOrg 5569695462Odengatan 79 4 TrComputer programming activities · NACE 6210Est. 20141-4 employees
Revenue 2024
SEK 6,2M
+9% vs 2023
EBITDA margin
30.8%
+51% vs 2023
Equity ratio
76.0%
Financial strength
Net profit 2024
SEK 659K
+87% vs 2023
| Revenue | SEK 6,2M | +9% |
| EBITDA | SEK 1,9M | +51% |
| Net profit | SEK 659K | +87% |
| Total assets | SEK 8,5M | +3% |
| Equity | SEK 6,4M | +11% |
| Employees | — | — |
Legal name
NQ Neuroquant AB
Org number
5569695462
Legal form
Aktiebolag
NACE code
6210 · Computer programming activities
Founded
23 april 2014
Share capital
SEK 66 882
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva rådgivning inom Al för finansiella tjänster och erbjuda tjänster inom finansiell kommunikation samt därmed förenlig verksamhet.
Address
Odengatan 79 4 Tr
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 170 | 3 147 | 5 667 | 6 174 |
| Staff expenses | — | — | — | — | −104 |
| EBITDA | −5 | −577 | 165 | 1 259 | 1 901 |
| Depreciation & amort. | −0 | −198 | −616 | −1 023 | −1 316 |
| EBIT | −5 | −775 | −451 | 236 | 586 |
| Net financials | — | — | — | 116 | 73 |
| Profit before tax | −5 | −775 | −451 | 352 | 659 |
| Tax | −0 | −0 | −0 | −0 | — |
| Net profit | −5 | −775 | −451 | 352 | 659 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 25 | 2 412 | 5 964 | 8 175 | 8 455 |
| Equity | 23 | 1 572 | 1 121 | 5 763 | 6 422 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 2 | 839 | 4 843 | 2 411 | 2 032 |
| Total debt | 2 | 839 | 4 843 | 2 411 | 2 032 |
EBITDA margin
30.8%
This company
15.8%
Market median
+95% vs market
20202024
Equity ratio
76.0%
This company
38.2%
Market median
+99% vs market
20202024
Return on equity
10.3%
This company
18.4%
Market median
+44% vs market
20202024
Net profit margin
10.7%
This company
8.1%
Market median
+32% vs market
20202024
Asset turnover
0.73×
This company
1.12×
Market median
-35% vs market
20202024
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NQ Neuroquant AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Olov Hansén | Board of Directors | 0 companies |
| Jens David Lennen | Chairman | 0 companies |
| Ann Malin Lennen | Deputy Board Member | 0 companies |